60 mg/kg azithromycin ER + 30 mg/kg azithromycin IR
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Otitis Media
Conditions
Acute Otitis Media
Trial Timeline
Dec 1, 2008 → Feb 1, 2009
NCT ID
NCT00796224About 60 mg/kg azithromycin ER + 30 mg/kg azithromycin IR
60 mg/kg azithromycin ER + 30 mg/kg azithromycin IR is a phase 2 stage product being developed by Pfizer for Acute Otitis Media. The current trial status is completed. This product is registered under clinical trial identifier NCT00796224. Target conditions include Acute Otitis Media.
What happened to similar drugs?
20 of 20 similar drugs in Acute Otitis Media were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00796224 | Phase 2 | Completed |
Competing Products
20 competing products in Acute Otitis Media